14.10.2016 • NewsElaine BurridgeReverdiaPU foams

Reverdia and Xinhuarun to Develop Bio-based PU Foams

(c) AVAVA/Shutterstock
(c) AVAVA/Shutterstock

Dutch biochemicals specialist Reverdia has signed an agreement with China’s Dezhou Xinhuarun Technology to jointly develop and promote microcellular PU foams based on bio-succinic acid. Reverdia’s Biosuccinium will be used in the foams which go into manufacturing footwear, shoe soles and other applications.

Liang Yanzhi, chair of the board at Xinhuarun, said the Dezhou, Shandong-based company will work exclusively with Reverdia. She commented: “Going forward, we will expand our work with Reverdia towards development and commercialization of other sustainable polymers in our strategic markets. These innovative materials address a potential market in excess of $500 million.

A joint venture between Royal DSM and French family-owned firm Roquette Frères, Reverdia is dedicated to the market development of Biosuccinium, which is based on renewable, plant-based resources. Reverdia began licensing the product and technology in 2014.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.